AnaptysBio Inc. (ANAB)
14.65
-2.17 (-12.90%)
At close: Mar 03, 2025, 3:59 PM
14.75
0.68%
After-hours: Mar 03, 2025, 04:19 PM EST
AnaptysBio Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 123.08M | 35.97M | 71.31M | 495.73M | 250.46M | 171.02M | 113.6M | 81.19M | 51.23M | 51.68M | 22.19M | 2.81M |
| Short-Term Investments | 262.29M | 354.94M | 369.93M | 52.37M | 143.2M | 203.21M | 313.49M | 167.22M | n/a | n/a | n/a | n/a |
| Long-Term Investments | 35.47M | 27.03M | 142.94M | 67.1M | 17.55M | 54.3M | 73.13M | 75.9M | 60K | 60K | n/a | n/a |
| Other Long-Term Assets | 256K | 256K | 256K | 256K | 662K | 1.54M | 208K | 106K | 3.44M | 2.21M | 85K | 110K |
| Receivables | n/a | 6.85M | 1.42M | 876K | n/a | n/a | 174K | 1.6M | 5.34M | 1.23M | 1.46M | n/a |
| Inventory | n/a | n/a | 1.00 | 1.00 | n/a | n/a | n/a | n/a | 1.00 | n/a | n/a | n/a |
| Other Current Assets | 46.5M | 9.08M | 4.54M | 4.9M | 5.82M | 7.01M | 6.96M | 2.69M | 1.63M | 1.11M | 1.52M | 244K |
| Total Current Assets | 431.88M | 406.83M | 447.2M | 553.88M | 396.56M | 377.73M | 434.22M | 252.7M | 58.21M | 53.46M | 24.4M | 3.05M |
| Property-Plant & Equipment | 16.23M | 18.27M | 19.99M | 21.84M | 1.78M | 1.62M | 1.45M | 665K | 471K | 551K | 579K | 750K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 51.96M | 45.55M | 163.18M | 89.19M | 19.99M | 57.46M | 74.78M | 76.67M | 3.97M | 2.82M | 664K | 860K |
| Total Assets | 483.83M | 452.39M | 610.38M | 643.07M | 416.55M | 435.2M | 509M | 329.36M | 62.18M | 56.28M | 25.07M | 3.91M |
| Account Payables | 4M | 4.7M | 2.78M | 1.74M | 4.22M | 16.24M | 5.44M | 2.32M | 2.28M | 1.52M | 415K | 197K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 10.18M | 8.7M | 4.86M | 3.43M | 2.94M | 10.09M | 1.29M |
| Short-Term Debt | 1.93M | 1.78M | 3.27M | 3.01M | 342K | 2.25M | 7.63M | 6.89M | 1K | 21K | 129K | 932K |
| Other Current Liabilities | 39.5M | 30.97M | 20M | 11.35M | 15.26M | 11.05M | 8.76M | 4.88M | 3.43M | 2.75M | 1.05M | 743K |
| Total Current Liabilities | 45.43M | 37.44M | 26.05M | 16.1M | 19.82M | 29.54M | 21.84M | 14.09M | 5.71M | 7.38M | 11.68M | 3.16M |
| Long-Term Debt | 14.11M | 16.04M | 17.81M | 19.45M | n/a | 654K | 625K | 7.55M | 13.81M | 4.9M | 4.79M | n/a |
| Other Long-Term Liabilities | 353.43M | 310.81M | 304.41M | 251.09M | n/a | n/a | 171K | 140K | 3.4M | 1.66M | 569K | 607K |
| Total Long-Term Liabilities | 367.54M | 326.84M | 322.23M | 270.54M | n/a | 654K | 796K | 7.69M | 17.2M | 6.57M | 7.39M | 607K |
| Total Liabilities | 412.97M | 364.29M | 348.28M | 286.64M | 19.82M | 30.19M | 22.63M | 21.78M | 22.91M | 13.94M | 19.07M | 3.77M |
| Total Debt | 16.04M | 17.81M | 19.45M | 20.95M | 342K | 2.25M | 8.26M | 14.45M | 13.81M | 4.92M | 4.92M | 932K |
| Common Stock | 30K | 27K | 29K | 28K | 27K | 27K | 27K | 24K | 3K | 3K | 17K | 17K |
| Retained Earnings | -759.33M | -614.1M | -450.48M | -321.75M | -263.96M | -244.03M | -146.69M | -85.03M | -54.92M | -50.66M | -45.26M | -48.79M |
| Comprehensive Income | 305K | -797K | -5.25M | -422K | -4K | 338K | -223K | -426K | -3.8M | -3.58M | -3.35M | -3.11M |
| Shareholders Equity | 70.87M | 88.1M | 262.1M | 356.43M | 396.73M | 405.01M | 486.37M | 307.58M | 39.27M | 42.34M | 5.99M | 145K |
| Total Investments | 297.76M | 381.96M | 512.87M | 119.47M | 160.74M | 257.51M | 386.61M | 243.12M | 60K | 60K | n/a | n/a |